Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Leu, Steve ^a   Lin, Yu Chun ^a   Yuen, Chun Man ^a   Yen, Chia Hung ^b   Kao, Ying Hsien ^c   Sun, Cheuk Kwan ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CXCR4; DOUBLECORTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 18; INTERLEUKIN 8; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BAX; PROTEIN BCL 2; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 4; VON WILLEBRAND FACTOR; 4',6 DIAMIDINO 2 PHENYLINDOLE; INDOLE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOTRANSPLANTATION; BRAIN FUNCTION; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVOUS SYSTEM DEVELOPMENT; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RAT; SENSORIMOTOR FUNCTION; SPRAGUE DAWLEY RAT; THERAPY EFFECT; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; CELL COUNT; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BRAIN INFARCTION; CELL COUNT; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLES; INFLAMMATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSPLANTATION, AUTOLOGOUS; VON WILLEBRAND FACTOR;

EID: 77953940699     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-63     Document Type: Article

References (35)

1. Hankey GJ. Stroke: how large a public health problem, and how can the neurologist help?. Arch Neurol 1999, 56:748-754. 10.1001/archneur.56.6.748, 10369318.
2. WHO The world health report 1999 - Making a difference. 1999, 65. Geneva, World Health Organization, WHO.
3. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci 2008, 265:73-77. 10.1016/j.jns.2007.06.012, 17610905.
4. Andres RH, Choi R, Steinberg GK, Guzman R. Potential of adult neural stem cells in stroke therapy. Regen Med 2008, 3:893-905. 10.2217/17460751.3.6.893, 18947311.
5. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003, CD000213.
6. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, . SITS-MOST investigators Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007, 369:275-282. 10.1016/S0140-6736(07)60149-4, 17258667, SITS-MOST investigators.
7. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, . American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655-1711. 10.1161/STROKEAHA.107.181486, 17431204, American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups.
8. Bravata DM. Intravenous thrombolysis in acute ischaemic stroke: optimising its use in routine clinical practice. CNS Drugs 2005, 19:295-302. 10.2165/00023210-200519040-00002, 15813643.
9. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Wardlaw J. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke 2004, 35:1490-1497. 10.1161/01.STR.0000126871.98801.6E, 15105519.
10. Thomalla G, Sobesky J, Kohrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Rother J, Schellinger PD. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke 2007, 38:313-318. 10.1161/01.STR.0000254565.51807.22, 17204683.
11. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918. 10.1161/01.CIR.0000034046.87607.1C, 12370212.
12. Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, Lee FY, Sun CK. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 2008, 72:1336-1345. 10.1253/circj.72.1336, 18654023.
13. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009, 37:1197-1205. 10.1097/CCM.0b013e31819c0667, 19242323.
14. Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009, 87:2183-2200. 10.1002/jnr.22054, 19301431.
15. Bakondi B, Shimada IS, Perry A, Munoz JR, Ylostalo J, Howard AB, Gregory CA, Spees JL. CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 2009, 17:1938-1947. 10.1038/mt.2009.185, 19690521.
16. Chen JR, Cheng GY, Sheu CC, Tseng GF, Wang TJ, Huang YS. Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. J Anat 2008, 213:249-258. 10.1111/j.1469-7580.2008.00948.x, 18647194.
17. Shen LH, Li Y, Chen J, Zhang J, Vanguri P, Borneman J, Chopp M. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006, 137:393-399. 10.1016/j.neuroscience.2005.08.092, 16298076.
18. Chang YC, Shyu WC, Lin SZ, Li H. Regenerative therapy for stroke. Cell Transplant 2007, 16:171-181.
19. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003, 183:355-366. 10.1016/S0014-4886(03)00089-X, 14552877.
20. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008, 26:2705-2712. 10.1634/stemcells.2008-0034, 18535155.
21. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, Lu M, Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002, 117:207-214. 10.1016/S0165-0270(02)00114-0, 12100987.
22. Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004, 24:159-171. 10.1111/j.1440-1789.2004.00552.x, 15484694.
23. Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, Hovatta O, Jolkkonen J. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci 2009, 29:562-574. 10.1111/j.1460-9568.2008.06599.x, 19175403.
24. Roh JK, Jung KH, Chu K. Adult stem cell transplantation in stroke: its limitations and prospects. Curr Stem Cell Res Ther 2008, 3:185-196. 10.2174/157488808785740352, 18782001.
25. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894. 10.1634/stemcells.2004-0342, 15888687.
26. Wei YJ, Tang Y, Li J, Cui CJ, Zhang H, Zhang XL, Hu SS. Cloning and expression pattern of dog SDF-1 and the implications of altered expression of SDF-1 in ischemic myocardium. Cytokine 2007, 40:52-59. 10.1016/j.cyto.2007.08.004, 17910919.
27. Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J Clin Invest 2006, 116:2808-2816. 10.1172/JCI28310, 1578623, 17016561.
28. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328. 10.1161/01.CIR.0000055313.77510.22, 12628955.
29. Kahn J, Byk T, Jansson-Sjostrand L, Petit I, Shivtiel S, Nagler A, Hardan I, Deutsch V, Gazit Z, Gazit D, Karlsson S, Lapidot T. Overexpression of CXCR4 on human CD34 + progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004, 103:2942-2949. 10.1182/blood-2003-07-2607, 15070669.
30. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005, 46:1799-1802. 10.1016/j.jacc.2005.07.053, 16286162.
31. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705. 10.1038/35070587, 11287958.
32. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223. 10.1161/CIRCULATIONAHA.104.527937, 15998673.
33. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005, 80:229-236. discussion 236-227, 10.1016/j.athoracsur.2005.02.072, 15975372.
34. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003, 361:47-49. 10.1016/S0140-6736(03)12111-3, 12517468.
35. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med 2002, 346:5-15. 10.1056/NEJMoa012081, 11777997.